Aridis Pharmaceuticals, Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2023 was -3.95 %, a 99.6% increase year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Operating Margin for 2022 was -970 %, a 65.1% increase from 2021.
  • Aridis Pharmaceuticals, Inc. annual Operating Margin for 2021 was -2.78K %, a 24.2% decline from 2020.
  • Aridis Pharmaceuticals, Inc. annual Operating Margin for 2020 was -2.24K %, a 21.3% increase from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -3.95 +1.08K +99.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -33.2 +1.47K +97.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -966 +623 +39.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -970 +1.81K +65.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.09K Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.5K Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.59K Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.78K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.